Teladoc Health News

Teladoc Health Benzinga / Apr 30, 2021

Cathie Wood-led Ark Investment Management bought a total of 716,269 shares, worth about $122.38 million, in Teladoc Health Inc (NYSE: TDOC) on Thursday as the stock slumped after the telemedicine company reported a wider-than-expected first-quarter loss. Teladoc shares closed 8.23% lower at $170.86 on Thursday.

Teladoc Health Motley Fool / Apr 30, 2021

David Gardner, a co-founder of The Motley Fool, often says that "winners win." And he's exactly right. However, he would be the first to tell you that winners don't win all of the time. They have their ups and downs. Case in point: Cathie Wood certainly qualifies as a winner.

Teladoc Health Nasdaq / Apr 30, 2021

I look at Ford's (NYSE: F) and Teladoc's (NYSE: TDOC) earnings in today's video. Here are three reasons these two stocks could be giving long-term investors a buying opportunity with their recent stock price dips.Three reasons Ford could be giving long-term investors a buying opp

Teladoc Health Investorplace.com / Apr 30, 2021

We've passed the peak of earnings season and are now on the descent. A few stragglers remain, but most industry titans have released their first-quarter numbers. Despite reporting impressive results, the market response in nearly all cases was muted. And as is always the case, there were a few companies that completely whiffed.

Teladoc Health pymnts.com / Apr 30, 2021

In today's top payments news around the world, Taster has notched a $37 million cash infusion from several outside investors, while Oura Health Oy is reportedly in talks with investors in regard to a possible fundraise that would value the company at $800 million.

Teladoc Health Yahoo Finance / Apr 30, 2021

Telemedicine Market Key Players Studied In this Report are American Well, GlobalMed, Teladoc Health, Inc, MeMD, InTouch Technologies, Inc., Doctor On Demand, Inc., MDLIVE Inc, Encounter Telemedicine, 2nd.MD, SnapMD, Inc.Pune, India, April 30, 2021 (GLOBE NEWSWIRE) -- According to the report, Telemedicine market size is projected reach USD 396.76 Billion by 2026.

Teladoc Health MedCity News / Apr 30, 2021

The rapid rise in healthcare costs has executives in the corporate world worried, and they want the government to play a bigger role in controlling it, according to a new report. The report, compiled by Purchaser Business Group on Health and the Kaiser Family Foundation, includes survey responses from executive decision-makers at 302 large private companies.

Teladoc Health KSU | The Sentinel Newspaper / Apr 30, 2021

LOS ANGELES, United States (2021): Stratagem Market Insights delivers key insights for the Emerging Mental Health Device and Platform Market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028) .

Teladoc Health Motley Fool / Apr 29, 2021

( Teladoc Health NYSE:TDOC) Q1 2021 Earnings Call, 4:30 p.m. ET Prepared Remarks Questions and Answers Call Participants Operator Ladies and gentlemen, thank you for standing by. And welcome to the Teladoc first-quarter 2021 earnings conference call. [Operator instructions] I will now turn the conference over to Patrick Feeley, vice president of investor relations.

Teladoc Health TheStreet / Apr 29, 2021

Teladoc Health shares fell Thursday as several analysts lowered their share-price targets for the online healthcare provider. The markdowns came after Teladoc reported weaker-than-expected quarterly profit. Teladoc posted a loss of $1.31 a share, widening from 40 cents last year. Analysts expected a first-quarter loss of 40 cents.

Teladoc Health MarketBeat / Apr 29, 2021

Teladoc Health (NYSE:TDOC) had its target price dropped by investment analysts at Oppenheimer from $270.00 to $250.00 in a research note issued to investors on Thursday, The Fly reports. Oppenheimer's price target points to a potential upside of 46.63% from the stock's previous close.

Teladoc Health Investing.com / Apr 29, 2021

13 hours ago (Apr 29, 2021 06:24AM ET) Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc (NYSE:) on Thursday, setting a price target of $235, which is approximately 26.13% above the present share price of $186.31. MacDonald expects Teladoc to post earnings per share (EPS) of -$3.07 for the second quarter of 2021.